Martin van Eijk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martin van Eijk has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Henk P. Haagsman
From the Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands
4 shared publications- Michael J. Rynkiewicz
Department of Physiology and Biophysics, Boston University School of Medicine, Boston, MA 02118, USA
2 shared publications Mitchell R. White
Medicine, and
2 shared publications- Albert D. M. E. Osterhaus
Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
1 shared publication - Anne-Laure Favier
Imagery Unit, Department of Platforms and Technology Research, French Armed Forces Biomedical Research Institute, 91223 Brétigny-sur-Orge, France
1 shared publication Barbara A. Seaton
The Departments of Physiology and Biophysics and
1 shared publication
Latest Publications
- Open Access
Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction
Since the largest 2014–2016 Ebola virus disease outbreak in West Africa, understanding of Ebola virus infection has improved, notably the involvement of innate immune mediators. Amongst them, collectins are important players in the antiviral innate immune defense. A screening of Ebola glycoprotein (GP)-collectins interactions revealed the specific interaction of human surfactant protein D (hSP-D), a lectin expressed in lung and liver, two compartments where Ebola was found in vivo. Further analyses have demonstrated an involvement of hSP-D in the enhancement of virus infection in several in vitro models. Similar effects were observed for porcine SP-D (pSP-D). In addition, both hSP-D and pSP-D interacted with Reston virus (RESTV) GP and enhanced pseudoviral infection in pulmonary cells. Thus, our study reveals a novel partner of Ebola GP that may participate to enhance viral spread.
Open AccessInvolvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction
Since the largest 2014–2016 Ebola virus disease outbreak in West Africa, understanding of Ebola virus infection has improved, notably the involvement of innate immune mediators. Amongst them, collectins are important players in the antiviral innate immune defense. A screening of Ebola glycoprotein (GP)-collectins interactions revealed the specific interaction of human surfactant protein D (hSP-D), a lectin expressed in lung and liver, two compartments where Ebola was found in vivo. Further analyses have demonstrated an involvement of hSP-D in the enhancement of virus infection in several in vitro models. Similar effects were observed for porcine SP-D (pSP-D). In addition, both hSP-D and pSP-D interacted with Reston virus (RESTV) GP and enhanced pseudoviral infection in pulmonary cells. Thus, our study reveals a novel partner of Ebola GP that may participate to enhance viral spread.
- Open Access
- 1 July 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (27) , 10646-10662
Lectin-mediated binding and sialoglycans of porcine surfactant protein D synergistically neutralize influenza A virus
- 1 July 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (27) , 10646-10662
Open AccessLectin-mediated binding and sialoglycans of porcine surfactant protein D synergistically neutralize influenza A virus
- Open Access
- 5 February 2013
- Published by S. Karger AG in Journal of Innate Immunity
- Vol. 5 (3) , 197-208
Pulmonary Surfactant Protein D in First-Line Innate Defence against Influenza A Virus Infections
Influenza A viruses (IAV) cause respiratory tract infections annually associated with excess mortality and morbidity. Nonspecific, innate immune mechanisms play a key role in protection against viral invasion at early stages of infection. A soluble protein present in mucosal secretions of the lung, surfactant protein D (SP-D), is an important component of this initial barrier that helps to prevent and limit IAV infections of the respiratory epithelium. This collagenous C-type lectin binds IAVs and thereby inhibits attachment and entry of the virus but also contributes to enhanced clearance of SP-D-opsonized virus via interactions with phagocytic cells. In addition, SP-D modulates the inflammatory response and helps to maintain a balance between effective neutralization/killing of IAV, and protection against alveolar damage resulting from IAV-induced excessive inflammatory responses. The mechanisms of interaction between SP-D and IAV not only depend on the structure and binding properties of SP-D but also on strain-specific features of IAV, and both issues will be discussed. SP-D from pigs exhibits distinct anti-IAV properties and is discussed in more detail. Finally, the potential of SP-D as a prophylactic and/or therapeutic antiviral agent to protect humans against infections by IAV is discussed.
- 5 February 2013
- Published by S. Karger AG in Journal of Innate Immunity
- Vol. 5 (3) , 197-208
Open AccessPulmonary Surfactant Protein D in First-Line Innate Defence against Influenza A Virus Infections
Influenza A viruses (IAV) cause respiratory tract infections annually associated with excess mortality and morbidity. Nonspecific, innate immune mechanisms play a key role in protection against viral invasion at early stages of infection. A soluble protein present in mucosal secretions of the lung, surfactant protein D (SP-D), is an important component of this initial barrier that helps to prevent and limit IAV infections of the respiratory epithelium. This collagenous C-type lectin binds IAVs and thereby inhibits attachment and entry of the virus but also contributes to enhanced clearance of SP-D-opsonized virus via interactions with phagocytic cells. In addition, SP-D modulates the inflammatory response and helps to maintain a balance between effective neutralization/killing of IAV, and protection against alveolar damage resulting from IAV-induced excessive inflammatory responses. The mechanisms of interaction between SP-D and IAV not only depend on the structure and binding properties of SP-D but also on strain-specific features of IAV, and both issues will be discussed. SP-D from pigs exhibits distinct anti-IAV properties and is discussed in more detail. Finally, the potential of SP-D as a prophylactic and/or therapeutic antiviral agent to protect humans against infections by IAV is discussed.
- Open Access
- 1 June 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (23) , 20137-20151
Introduction of N-Linked Glycans in the Lectin Domain of Surfactant Protein D
- 1 June 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (23) , 20137-20151
Open AccessIntroduction of N-Linked Glycans in the Lectin Domain of Surfactant Protein D
- 1 December 1995
- Published by Elsevier in Analytical Biochemistry
- Vol. 232 (2) , 231-237
Quantitative Analysis of Pulmonary Surfactant Proteins B and C
- 1 December 1995
- Published by Elsevier in Analytical Biochemistry
- Vol. 232 (2) , 231-237
Quantitative Analysis of Pulmonary Surfactant Proteins B and C